메뉴 건너뛰기




Volumn 25, Issue 3, 2015, Pages 212-215

Upper limb module in non-ambulant patients with spinal muscular atrophy: 12 month changes

Author keywords

Hammersmith; Outcome measure; Spinal muscular atrophy; Upper limb

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; FUNCTIONAL STATUS; FUNCTIONAL STATUS ASSESSMENT; HAMMERSMITH FUNCTIONAL MOTOR SCALE EXPANDED; HUMAN; IMMOBILITY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SPINAL MUSCULAR ATROPHY; UPPER LIMB MODULE; ARM; DISEASE COURSE; GENETICS; LONGITUDINAL STUDY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; TIME; YOUNG ADULT;

EID: 84924282508     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2014.11.008     Document Type: Article
Times cited : (27)

References (22)
  • 1
    • 26944503463 scopus 로고    scopus 로고
    • 134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy, 11-13 February 2005, Naarden, The Netherlands
    • Bertini E., Burghes A., Bushby K., et al. 134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy, 11-13 February 2005, Naarden, The Netherlands. Neuromuscul Disord 2005, 15:802-816.
    • (2005) Neuromuscul Disord , vol.15 , pp. 802-816
    • Bertini, E.1    Burghes, A.2    Bushby, K.3
  • 2
    • 70350710787 scopus 로고    scopus 로고
    • Clinical outcome measures in spinal muscular atrophy
    • Montes J., Gordon A.M., Pandya S., et al. Clinical outcome measures in spinal muscular atrophy. J Child Neurol 2009, 24:968-978.
    • (2009) J Child Neurol , vol.24 , pp. 968-978
    • Montes, J.1    Gordon, A.M.2    Pandya, S.3
  • 3
    • 53249098299 scopus 로고    scopus 로고
    • Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th-13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June-1st July 2007, Naarden, The Netherlands; conjoint Institute of Myology TREAT-N
    • Mercuri E., Mayhew A., Muntoni F., et al. Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th-13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June-1st July 2007, Naarden, The Netherlands; conjoint Institute of Myology TREAT-NMD meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France. Neuromusc Disord 2008, 18:894-903.
    • (2008) Neuromusc Disord , vol.18 , pp. 894-903
    • Mercuri, E.1    Mayhew, A.2    Muntoni, F.3
  • 4
    • 0043092414 scopus 로고    scopus 로고
    • The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation
    • Main M., Kairon H., Mercuri E., et al. The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol 2003, 7:155-159.
    • (2003) Eur J Paediatr Neurol , vol.7 , pp. 155-159
    • Main, M.1    Kairon, H.2    Mercuri, E.3
  • 5
    • 82455168056 scopus 로고    scopus 로고
    • Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III
    • Glanzman A.M., O'Hagen J.M., McDermott M.P., et al. Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III. J Child Neurol 2011, 26:1499-1507.
    • (2011) J Child Neurol , vol.26 , pp. 1499-1507
    • Glanzman, A.M.1    O'Hagen, J.M.2    McDermott, M.P.3
  • 6
    • 34548426950 scopus 로고    scopus 로고
    • An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients
    • O'Hagen J.M., Glanzman A.M., McDermott M.P., et al. An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. Neuromusc Disord 2007, 17:693-697.
    • (2007) Neuromusc Disord , vol.17 , pp. 693-697
    • O'Hagen, J.M.1    Glanzman, A.M.2    McDermott, M.P.3
  • 7
    • 33746355222 scopus 로고    scopus 로고
    • A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy
    • Krosschell K.J., Maczulski J.A., Crawford T.O., et al. A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy. Neuromusc Disord 2006, 16:417-426.
    • (2006) Neuromusc Disord , vol.16 , pp. 417-426
    • Krosschell, K.J.1    Maczulski, J.A.2    Crawford, T.O.3
  • 8
    • 79960553384 scopus 로고    scopus 로고
    • Reliability of the Modified Hammersmith Functional Motor Scale in young children with spinal muscular atrophy
    • Krosschell K.J., Scott C.B., Maczulski J.A., et al. Reliability of the Modified Hammersmith Functional Motor Scale in young children with spinal muscular atrophy. Muscle Nerve 2011, 44:246-251.
    • (2011) Muscle Nerve , vol.44 , pp. 246-251
    • Krosschell, K.J.1    Scott, C.B.2    Maczulski, J.A.3
  • 9
    • 46849115152 scopus 로고    scopus 로고
    • Outcome measure for SMA II and III patients
    • author reply 594-595
    • Berard C., Fermanian J., Payan C. Outcome measure for SMA II and III patients. Neuromusc Disord 2008, 18:593-594. author reply 594-595.
    • (2008) Neuromusc Disord , vol.18 , pp. 593-594
    • Berard, C.1    Fermanian, J.2    Payan, C.3
  • 10
    • 33645769504 scopus 로고    scopus 로고
    • A motor function measurement scale for neuromuscular diseases - description and validation study
    • Berard C., Payan C., Fermanian J., et al. A motor function measurement scale for neuromuscular diseases - description and validation study. Rev Neurol (Paris) 2006, 162:485-493.
    • (2006) Rev Neurol (Paris) , vol.162 , pp. 485-493
    • Berard, C.1    Payan, C.2    Fermanian, J.3
  • 11
    • 84886727215 scopus 로고    scopus 로고
    • Motor function measure: validation of a short form for young children with neuromuscular diseases
    • De Lattre C., Payan C., Vuillerot C., et al. Motor function measure: validation of a short form for young children with neuromuscular diseases. Arch Phys Med Rehabil 2013, 94:2218-2226.
    • (2013) Arch Phys Med Rehabil , vol.94 , pp. 2218-2226
    • De Lattre, C.1    Payan, C.2    Vuillerot, C.3
  • 12
    • 84892504278 scopus 로고    scopus 로고
    • SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy
    • Kissel J.T., Elsheikh B., King W.M., et al. SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy. Muscle Nerve 2014, 49:187-192.
    • (2014) Muscle Nerve , vol.49 , pp. 187-192
    • Kissel, J.T.1    Elsheikh, B.2    King, W.M.3
  • 13
    • 79959988589 scopus 로고    scopus 로고
    • SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy
    • Kissel J.T., Scott C.B., Reyna S.P., et al. SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy. PLoS ONE 2011, 6:e21296.
    • (2011) PLoS ONE , vol.6 , pp. e21296
    • Kissel, J.T.1    Scott, C.B.2    Reyna, S.P.3
  • 14
    • 9144269242 scopus 로고    scopus 로고
    • Pilot trial of phenylbutyrate in spinal muscular atrophy
    • Mercuri E., Bertini E., Messina S., et al. Pilot trial of phenylbutyrate in spinal muscular atrophy. Neuromusc Disord 2004, 14:130-135.
    • (2004) Neuromusc Disord , vol.14 , pp. 130-135
    • Mercuri, E.1    Bertini, E.2    Messina, S.3
  • 15
    • 33846114574 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy
    • Mercuri E., Bertini E., Messina S., et al. Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. Neurology 2007, 68:51-55.
    • (2007) Neurology , vol.68 , pp. 51-55
    • Mercuri, E.1    Bertini, E.2    Messina, S.3
  • 16
    • 46749083736 scopus 로고    scopus 로고
    • Daily salbutamol in young patients with SMA type II
    • Pane M., Staccioli S., Messina S., et al. Daily salbutamol in young patients with SMA type II. Neuromusc Disord 2008, 18:536-540.
    • (2008) Neuromusc Disord , vol.18 , pp. 536-540
    • Pane, M.1    Staccioli, S.2    Messina, S.3
  • 17
    • 21244460238 scopus 로고    scopus 로고
    • A motor function measure for neuromuscular diseases. Construction and validation study
    • Berard C., Payan C., Hodgkinson I., et al. A motor function measure for neuromuscular diseases. Construction and validation study. Neuromusc Disord 2005, 15:463-470.
    • (2005) Neuromusc Disord , vol.15 , pp. 463-470
    • Berard, C.1    Payan, C.2    Hodgkinson, I.3
  • 18
    • 84893953276 scopus 로고    scopus 로고
    • Rasch analysis of clinical outcome measures in spinal muscular atrophy
    • Cano S.J., Mayhew A., Glanzman A.M., et al. Rasch analysis of clinical outcome measures in spinal muscular atrophy. Muscle Nerve 2013, 49:422-430.
    • (2013) Muscle Nerve , vol.49 , pp. 422-430
    • Cano, S.J.1    Mayhew, A.2    Glanzman, A.M.3
  • 19
    • 84895795209 scopus 로고    scopus 로고
    • Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients
    • Mazzone E., De Sanctis R., Fanelli L., et al. Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients. Neuromusc Disord 2014, 24:347-352.
    • (2014) Neuromusc Disord , vol.24 , pp. 347-352
    • Mazzone, E.1    De Sanctis, R.2    Fanelli, L.3
  • 20
    • 79956124923 scopus 로고    scopus 로고
    • Assessing upper limb function in nonambulant SMA patients: development of a new module
    • Mazzone E., Bianco F., Martinelli D., et al. Assessing upper limb function in nonambulant SMA patients: development of a new module. Neuromusc Disord 2011, 21:406-412.
    • (2011) Neuromusc Disord , vol.21 , pp. 406-412
    • Mazzone, E.1    Bianco, F.2    Martinelli, D.3
  • 21
    • 79958724642 scopus 로고    scopus 로고
    • Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year
    • Kaufmann P., McDermott M.P., Darras B.T., et al. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Arch Neurol 2011, 68:779-786.
    • (2011) Arch Neurol , vol.68 , pp. 779-786
    • Kaufmann, P.1    McDermott, M.P.2    Darras, B.T.3
  • 22
    • 84871313487 scopus 로고    scopus 로고
    • Prospective cohort study of spinal muscular atrophy types 2 and 3
    • Kaufmann P., McDermott M.P., Darras B.T., et al. Prospective cohort study of spinal muscular atrophy types 2 and 3. Neurology 2012, 79:1889-1897.
    • (2012) Neurology , vol.79 , pp. 1889-1897
    • Kaufmann, P.1    McDermott, M.P.2    Darras, B.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.